Clinical Remissions In Three Otherwise Intractable Cancers Signal The ...

Oct 13, 2009 Full story: MediLexicon

Epeius Biotechnologies Corporation announced more stunning results of its pioneering clinical studies of Rexin-G, the world's first and, so far only, tumor-targeted genetic medicine to be validated in the clinic.

Full Story
George Cooper

Charleston, SC

#1 Oct 14, 2009
This agent has orphan drug status via the FDA as well as Fast Track Designation in a number of solid tumors, so it is probably not without some credibility.

I wonder why on earth is there nothing in the prostate cancer literature or web sites about it?
Antony
#2 Sep 23, 2013
I have ordered 2 times from this website PILLSMEDSHOP. COM . I called yesterday the customer care and asked for a discount as i was about to order twice the regular amount.

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Oncology Discussions

Title Updated Last By Comments
Myeloma Awareness Day held at Queen's Park Dec 14 kids catching on too 1
Cancer Test Dec 12 kurtcooksalot16 1
Therapy found effective in older, African-Ameri... Nov 26 Zombie Corpse Rental 1
Black women die more often from breast cancer t... Oct '14 Spotted Girl 1
Doctors: Being Overweight Increases Risk for Ca... Oct '14 Does Not Compute 1
Breast Cancer Study Sep '14 paddyomalley 8
The Lancet journals: Three-quarters of depresse... Aug '14 MMR CAUSES AUTISM 2
More from around the web